| Parameters |
Group |
I |
II |
III |
IV |
| Dose |
0 mg/kg |
750 mg/kg |
400 mg/kg |
400 + 750 mg/kg |
| Mean No. of Live Fetuses |
Mean |
9.89 |
8.11 |
10.13 |
9.67 |
| SD |
2.80 |
2.85 |
1.64 |
3.24 |
| n |
9 |
9 |
8 |
9 |
| Mean No. of Male Fetuses |
Mean |
6.00 |
4.38 |
4.88 |
4.78 |
| SD |
3.54 |
1.85 |
1.64 |
2.39 |
| n |
9 |
8 |
8 |
9 |
| Mean No. of Female Fetuses |
Mean |
4.25 |
4.22 |
5.50 |
4.89 |
| SD |
2.12 |
2.44 |
1.41 |
2.03 |
| n |
8 |
9 |
8 |
9 |
| % Male Fetuses |
Mean |
59.65 |
51.58 |
46.57 |
48.76 |
| SD |
22.12 |
22.09 |
12.58 |
14.64 |
| n |
9 |
8 |
8 |
9 |
Group I : Control Group II: β Cyclodextrin, III: Tolbutamide IV: β Cyclodextrin + tolbutamide. |